One Atomic Substitution, Two Giant Hurdles of Disclosure and Efficacy
In Intra Cellular Therapies v. Controller of Patents, the Delhi High Court revisited two recurring fault lines in pharmaceutical patent law: the coverage disclosure distinction in...